Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Multiple myeloma (MM) therapeutics have evolved tremendously in recent years, with significant improvement in patient outcomes. As newer treatment options are developed, stem cell transplant (SCT) remains an important modality that provides excellent disease control and delays the progression of disease. Over the years, SCT use has increased overall in the U.S., but two distinct gaps remain, including suboptimal use overall and racial-ethnic disparities. We evaluated the National Cancer Database (NCDB) to study what sociodemographic factors might play a role within a given racial-ethnic group leading to disparate SCT utilization, such that targeted approaches can be developed to optimize SCT use for all. In nearly 112,000 cases belonging to mutually exclusive categories of non-Hispanic Whites (NHW), non-Hispanic Blacks (NHB), Hispanics, non-Hispanic Asians (NHA), and others, we found certain factors including age, comorbidity index, payor type, facility type (academic vs. community) and facility volume to be uniformly associated with SCT use for all the racial-ethnic groups, while gender was not significant for any of the groups. There were several other factors that had a differential impact on SCT utilization among the various race-ethnicity groups studied, including year of diagnosis (significant for NHW, NHB, and Hispanics), income level (significant for NHW and Hispanics), literacy level (significant for NHW and NHB), and geographic location of the treatment facility (significant for NHW and NHA). The suboptimal SCT utilization overall in the U.S. suggests that there may be room for improvement for all, even including the majority NHW, while we continue to work on factors that lead to disparities for the traditionally underserved populations. This study helps identify sociodemographic factors that may play a role specifically in each group and paves the way to devise targeted solutions such that resource utilization and impact can be maximized.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11133435PMC
http://dx.doi.org/10.1038/s41408-024-01067-xDOI Listing

Publication Analysis

Top Keywords

sct utilization
12
stem cell
8
cell transplant
8
multiple myeloma
8
sociodemographic factors
8
factors play
8
play role
8
nhb hispanics
8
nhw nhb
8
level nhw
8

Similar Publications

Defect Engineering-Driven Electron Spin Polarization and Charge Transfer in MOFs for Enhanced Sonocatalytic Therapy.

Adv Mater

September 2025

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Organic-Inorganic Composites, Bionanomaterials & Translational Engineering Laboratory, Beijing Key Laboratory of Bioprocess, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical

Sonocatalytic therapy (SCT) is a non-invasive tumor treatment modality that utilizes ultrasound (US)- activated sonocatalysts to generate reactive oxygen species (ROS), whose production critically dependent on the electronic structural properties of the catalytic sites. However, the spin state, which is a pivotal descriptor of electronic properties, remains underappreciated in SCT. Herein, a Ti-doped zirconium-based MOF (Ti-UiO-66, denoted as UTN) with ligand-deficient defects is constructed for SCT, revealing the important role of the electronic spin state in modulating intrinsic catalytic activity.

View Article and Find Full Text PDF

"Sickle cell trait and the risk for malignancy".

J Natl Med Assoc

September 2025

Howard University Department of Internal Medicine, Washington, DC, USA; Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, USA.

Introduction: Sickle cell trait (SCT) is a hereditary condition that affects millions worldwide, predominantly in individuals of African, Mediterranean, and Middle Eastern descent. While traditionally considered a benign carrier state, emerging evidence suggests a potential association between SCT and malignancies. This study aims to evaluate the relationship between SCT and the risk of multiple myeloma, renal cancer, leukemia, hepatocellular carcinoma (HCC), and colorectal cancer.

View Article and Find Full Text PDF

Contemporary information on epidemiology, healthcare resource utilization (HCRU), costs and clinical outcomes in routine care is essential for value-based decision-making. However, such information remains limited for follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in Germany. This study addresses these gaps.

View Article and Find Full Text PDF

Clinical Relevance: Understanding early microvascular alterations in the retinal and choroidal structures of patients with diabetes mellitus is essential for the timely identification of high-risk individuals and the prevention of vision-threatening complications.

Background: This study evaluates the impact of diabetes mellitus (DM) on retinal and choroidal vascular structures using optical coherence tomography angiography (OCTA) in pre-retinopathic patients. It also explores the relationship between OCTA parameters and HbA1c levels, a marker of long-term glycaemic control.

View Article and Find Full Text PDF

Background: The outcomes of clinical trials on stem cell therapy (SCT) on erectile dysfunction (ED) treatment are promising but there is still no conclusive evidence regarding its efficacy. The aim of this meta-analysis is to compile studies that assess the effectiveness of SCT on ED to reach a more reliable conclusion.

Methods: The meta-analysis was registered to PROSPERO (CRD42024540511).

View Article and Find Full Text PDF